NIH to Investigate Minor Cannabinoids and Terpenes for Potential Pain-Relieving Properties

Nine new research awards totaling approximately $3 million will investigate the potential pain-relieving properties and mechanisms of actions of the diverse phytochemicals in cannabis, including both minor cannabinoids a...
Continue reading

Association Between Medical Cannabis Laws and Opioid Overdose Mortality has Reversed Over Time

​Medical cannabis has been touted as a solution to the US opioid overdose crisis since Bachhuber et al. [M. A. Bachhuber, B. Saloner, C. O. Cunningham, C. L. Barry, JAMA Intern. Med. 174, 1668–1673] found that from 1999 to 2010 states with medical cannabis laws experienced slower increases in opioid analgesic overdose mortality. That research received substantial attention in the scientific literature and popular press and served as a talking point for the cannabis industry and its advocates, despite caveats from the authors and others to exercise caution when using ecological correlations to draw causal, individual-level conclusions.

Continue reading

AAPM Issues Updated Position Statement on Research into the Use of Cannabinoids for Medical Purposes

​ More than 30 states as well as Washington D.C. have legalized cannabis for medical purposes, making it more accessible than ever before to patients throughout the country, including patients suffering from chronic pain...
Continue reading

2019 AAPM Meeting Highlights from Practical Pain Management

Read articles about the latest pain research present at AAPM35 in Denver, March 6-10, 2019. 

Continue reading

Become part of this distinguished, multimodal, interdisciplinary community.

Join AAPM